GC
OME

Guggenheim Capital’s Omega Protein OME Stock Holding History

Guggenheim Capital’s Portfolio OME Stock Details OME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-24,502
Closed -$544K – 3045
2015
Q4 		$544K Sell
24,502
-80,754
-77% -$1.68M ﹤0.01% 2411
2015
Q3 		$1.79M Buy
105,256
+25,685
+32% +$400K 0.01% 1679
2015
Q2 		$1.09M Sell
79,571
-1,548
-2% -$20.6K ﹤0.01% 2175
2015
Q1 		$1.11M Buy
81,119
+66,698
+463% +$770K ﹤0.01% 2176
2014
Q4 		$153K Buy
14,421
+4,192
+41% +$49.6K ﹤0.01% 2820
2014
Q3 		$128K Sell
10,229
-5,215
-34% -$72.7K ﹤0.01% 2873
2014
Q2 		$212K Buy
15,444
+957
+7% +$12.5K ﹤0.01% 2888
2014
Q1 		$175K Buy
14,487
+2,310
+19% +$26.5K ﹤0.01% 2920
2013
Q4 		$150K Buy
12,177
+639
+6% +$7.5K ﹤0.01% 2909
2013
Q3 		$117K Buy
11,538
+1,148
+11% +$10.7K ﹤0.01% 2838
2013
Q2 		$93K Buy
+10,390
New +$105K ﹤0.01% 2832

Other funds holding OME

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T
Tinicum New York $67.3M AUM 7.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Guggenheim Capital's OME Position: Q1 2016 in Review

Guggenheim Capital sold out of Omega Protein (OME) in Q1 2016, closing a stake of 24,502 shares — an estimated $544K sold.

Guggenheim Capital first reported a position in OME in Q2 2013 and held it in 11 quarters. The position peaked at $1.79M in Q3 2015. 141 funds tracked by Wall St. Rank hold OME as of Q1 2016.

  • Guggenheim Capital reported no remaining Omega Protein position as of Q1 2016 after selling out during the quarter.
  • Guggenheim Capital sold 24,502 Omega Protein shares in Q1 2016, an estimated $544K.
  • Guggenheim Capital first reported a position in Omega Protein in Q2 2013 and held it in 11 quarters.
  • Guggenheim Capital's Omega Protein position peaked at $1.79M in Q3 2015.
  • 141 funds tracked by Wall St. Rank held Omega Protein as of Q1 2016.

Based on Guggenheim Capital's 13F filing for Q1 2016, filed 16 May 2016.